Market Overview: Santa Finally Shows Up

We're in the middle of holiday trading, so let's keep this focused on what matters. Stocks finished higher as Santa Claus finally made an appearance. The S&P 500 led the pack with a 1.40% gain for the week. The Nasdaq climbed 1.22%, while the Dow Jones Industrial Average added 1.20%.

Here's the thing: I still need to see a new high in the Nasdaq before giving the all-clear signal. But underneath the surface, good things continue to happen in the market. The biggest story, though? Metals have absolutely exploded, with silver leading the charge into parabolic territory. At this point, there's really nothing to do. It's too late to chase the move, and you'd be crazy to sell short. Sometimes the best trade is just sitting back with popcorn and watching history unfold.

Two Stocks Worth Your Attention

DBV Technologies (DBVT) – 47% Return Potential

The Setup

DBV Technologies S.A. is a clinical-stage biopharmaceutical company that's doing something genuinely interesting in the allergy treatment space. They've developed a proprietary platform called Viaskin that delivers epicutaneous immunotherapy (EPIT). Translation: they're treating food allergies through the skin rather than making kids eat what they're allergic to. It's a non-invasive approach focused on peanut and milk allergies in children, which gives investors exposure to the rapidly growing immunotherapy sector.

The financials tell a familiar biotech story. Last quarter brought in $2.38 million in revenue but posted a $28.44 million loss. The valuation is stretched with Book Value at just 1.31, and the company carries significant debt. From a technical perspective, DBVT recently broke out from a wedge formation. It's retesting that breakout now, and if support holds, the setup turns very bullish.

Why This Matters

DBV Technologies is positioned for a major breakthrough in peanut allergy treatment following positive topline results from the Phase 3 VITESSE trial of its VIASKIN Peanut patch in children aged 4-7 years, announced in December 2025. The trial hit its primary endpoint with a statistically significant treatment effect—46.6% of patients responded versus just 14.8% on placebo. This non-invasive epicutaneous immunotherapy offers a convenient, safer alternative to oral therapies, addressing a critical unmet need in a market affecting millions of children. The company plans to submit a Biologics License Application (BLA) in the first half of 2026.

The regulatory path is accelerating, and commercialization readiness is strengthening the company's momentum. The trial's success triggered warrant exercises that provided additional funding, and the FDA has aligned on safety data requirements. This positions the company for potential priority review, followed by a BLA for ages 1-3 in the second half of 2026. VIASKIN Peanut could become a first-in-class, patient-friendly solution in the growing food allergy immunotherapy space.

The pipeline validation builds confidence in the platform itself. Positive long-term data from studies like EPITOPE show continued benefit through 36 months in toddlers. These ongoing advancements highlight the technology's efficacy and safety profile, diversifying potential applications beyond peanut allergy while reinforcing the company's leadership in innovative, skin-based treatments for immunologic conditions.

Strategic leadership enhancements signal execution strength. Recent appointments include a new Chief Commercial Officer and board members with deep expertise, equipping DBV to navigate regulatory milestones and prepare for a potential U.S. launch. This creates a compelling narrative of a well-resourced biotech transitioning from clinical success to commercial impact.

Analyst sentiment supports the thesis. HC Wainwright rates it a Buy, Cantor Fitzgerald has it at Overweight, and Citizens gives it a Market Outperform rating.

The Trade

I'm bullish on DBVT above $14.50-$15.00. My upside target sits at $28.00-$30.00, representing roughly 47% return potential from current levels.

Hertz (HTZ) – 77% Return Potential

The Setup

Hertz Global Holdings, Inc. operates one of the world's largest car rental networks under the Hertz, Dollar, Thrifty, and Firefly brands. They offer daily and longer-term rentals along with ancillary services and used vehicle sales, providing exposure to the mobility and travel services sector with focus on airport and leisure travel, fleet management, and innovative customer experiences.

The numbers are starting to look interesting. Last quarter brought $2.48 billion in revenue along with $43 million in earnings. Valuation looks solid here. Price-to-Sales sits at 0.20 and EV to EBITDA is at 8.30. From a technical standpoint, HTZ has been coiling within a descending channel for months. This pattern is setting up what could be an epic short squeeze.

Why This Matters

Hertz Global Holdings Inc. is staging a genuine turnaround story in the car rental sector. The company returned to positive EPS profitability in Q3 2025 after years of challenges, driven by disciplined fleet management, higher vehicle utilization, and strategic retail sales. With record utilization levels and a renewed focus on core operations under new leadership, the company is rebuilding investor confidence amid stabilizing travel demand and operational efficiencies.

High-profile backing from Bill Ackman adds significant credibility and upside potential. Pershing Square holds a substantial stake, and Ackman's recent social media endorsement of bullish analyses sparked an 11.8% surge in late December 2025. This highlights growing optimism about Hertz's recovery path and potential for strategic value creation in a recovering market.

Strong Q3 2025 financial momentum signals improving fundamentals. The company achieved a surprise profit with adjusted EPS well above expectations, alongside revenue stability and reduced depreciation costs. This reflects successful execution of the "back-to-basics" transformation, positioning Hertz to benefit from seasonal travel rebounds and enhanced pricing power in key markets.

Fleet optimization and diversification efforts enhance long-term resilience. By streamlining the vehicle portfolio after electric vehicle adjustments, expanding retail sales channels like Hertz Car Sales, and pursuing partnerships for broader mobility solutions, the company is reducing volatility, improving cash flow, and adapting to evolving consumer preferences in a competitive landscape.

Here's the kicker: this is a strong candidate for a short squeeze with over 43% of floated shares being sold short. That's a massive short position that could fuel a rapid move higher if the turnaround story gains traction.

Analyst ratings remain cautious but not bearish. Morgan Stanley has it at Equal-Weight, Susquehanna rates it Neutral, and Jefferies maintains a Hold rating.

The Trade

I'm bullish on HTZ above $4.80-$5.00. My upside target is $9.50-$10.00, representing approximately 77% return potential.

Market-Moving Catalysts for the Week Ahead

Now, the Santa Claus Rally Period

The Santa Claus Rally is a well-documented seasonal stock market phenomenon referring to the historical tendency for stock prices to rise during the last five trading days of December and the first two trading days of January. That's a seven-trading-day window that's worth paying attention to.

Yale Hirsch coined the term in the 1972 Stock Trader's Almanac, and the pattern has occurred about 76-80% of the time since 1950. During this period, the S&P 500 has averaged a 1.3% gain, compared to a typical seven-day return of around 0.2%. Those are meaningful odds.

What causes it? The explanations range from holiday optimism to year-end tax strategies, bonus-driven investments, and lighter trading volume from institutional investors on vacation. When the big money is away, retail buyers can push prices higher more easily. Interestingly, absence of the rally has sometimes signaled weaker performance in the following year, though it's not a guaranteed predictor of anything.

Sector and Industry Strength

As we head into the final week of 2025, it's clear that healthcare (XLV) dominated the fourth quarter. The rest of the sectors are huddling in a pretty tight pack, except for utilities (XLU) and real estate (XLRE) lagging behind.

While it's encouraging to see utilities and real estate at the bottom of the pack, the outperformance of healthcare sets a somewhat cautionary tone going into the new year. We need to see more from the growth sectors for that dynamic to change.

The good news? Technology (XLK) is still positioned to quickly change the tone. Financials (XLF) are sitting in second place, and that's simply not where you'd see such a sector if the market was about to roll over. The setup suggests more choppy action in the near-term rather than a decisive move in either direction.

Looking at relative strength across different timeframes: Basic Materials leads over one week, Financials over three weeks, Healthcare over 13 weeks, and Technology over 26 weeks. The tape is in expansion mode, which is a positive sign for market breadth.

A Golden Year for Silver

2025 will go down in the record books as silver's year. It's the best-performing asset by far, and honestly, it has exceeded my own expectations in terms of performance by a wide margin. Looking at the ratio between gold (GLD) and silver (SLV) tells the story clearly.

Unsurprisingly, this ratio has completely collapsed over the past few months as silver outperformed gold by a very wide margin. If you go back and study history, this is the type of price action that typically precedes key tops. The moves get parabolic, everyone gets excited, and then things reverse hard.

In the meantime, we're in the blowoff phase of this move. Prices could still go higher, but in reality, it's become too dangerous to chase and too dangerous to short. It's genuinely best to wait for the dust to settle on this historic move. Sometimes the hardest thing to do in markets is nothing, but that's exactly what the situation calls for right now.

Cryptocurrency Continues to Show Weakness

The price action in Bitcoin continues to warn of additional downside. It's been effectively consolidating its losses over the past month. As a rule, this type of consolidation after a decline warns that lower prices are on the horizon, but prices would need to break support for further confirmation.

Unless Bitcoin can rally back above the 94,000-95,000 level, there are significant downside risks. It's been making lower lows and lower highs, which by definition means a bear trend is in effect. Trends are notorious for lasting longer than most people expect, so don't assume this will reverse quickly just because you want it to.

A final washout down to the 74,000-76,000 zone cannot be ruled out entirely. If that happens, it may actually present a unique buying opportunity, as the odds of crypto having back-to-back bearish years is not very likely based on historical patterns. Sometimes the best opportunities come after everyone has been thoroughly shaken out.

Legal Disclosures:

This communication is provided for information purposes only.

This communication has been prepared based upon information, including market prices, data and other information, from sources believed to be reliable, but MarketDash does not warrant its completeness or accuracy except with respect to any disclosures relative to MarketDash and/or its affiliates and an analyst's involvement with any company (or security, other financial product or other asset class) that may be the subject of this communication. Any opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice. Past performance is not indicative of future results. This communication is not intended as an offer or solicitation for the purchase or sale of any financial instrument. MarketDash does not provide individually tailored investment advice. Any opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not intended as recommendations of particular securities, financial instruments or strategies to particular clients. You must make your own independent decisions regarding any securities, financial instruments or strategies mentioned or related to the information herein. Periodic updates may be provided on companies, issuers or industries based on specific developments or announcements, market conditions or any other publicly available information. However, MarketDash may be restricted from updating information contained in this communication for regulatory or other reasons. Clients should contact analysts and execute transactions through a MarketDash subsidiary or affiliate in their home jurisdiction unless governing law permits otherwise. This communication may not be redistributed or retransmitted, in whole or in part, or in any form or manner, without the express written consent of MarketDash. Any unauthorized use or disclosure is prohibited. Receipt and review of this information constitutes your agreement not to redistribute or retransmit the contents and information contained in this communication without first obtaining express permission from an authorized officer of MarketDash.